v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Operating activities    
Net income $ 15,638 $ 19,014
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for allowance for credit losses on accounts and notes receivable 3,652 3,284
Depreciation and amortization 36,977 37,162
Deferred income taxes 664 1,600
Stock-based compensation expense 7,466 7,493
Refranchising and impairment (gain) loss (1,035) 1,693
Loss on disposal of property and equipment 729 2,576
Other 1,490 237
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 3,717 1,082
Income tax receivable 4,624 (308)
Inventories 1,567 (1,980)
Prepaid expenses and other current assets (4,651) (3,693)
Other assets and liabilities (5,796) (3,160)
Accounts payable 6,657 12,609
Income and other taxes payable (116) (6,132)
Accrued expenses and other current liabilities (20,686) (9,315)
Deferred revenue (5,961) (3,812)
Advertising fund assets and liabilities (9,108) 8,493
Net cash provided by operating activities 35,828 66,843
Investing activities    
Purchases of property and equipment (26,356) (30,305)
Purchases of property and equipment related to damages from natural disasters (1,221) (1,366)
Insurance proceeds related to damages from natural disasters 850 2,900
Repayments of notes issued 1,256 4,534
Proceeds from dispositions and refranchising, net of cash transferred 4,295 0
Proceeds from investments 3,232 4,739
Other 0 109
Net cash used in investing activities (17,944) (19,389)
Financing activities    
Net proceeds (repayments) of revolving credit facilities 11,259 (212,927)
Proceeds from term loan 0 200,000
Debt issuance costs 0 (3,223)
Proceeds from exercise of stock options 0 397
Dividends paid to common stockholders (30,864) (30,493)
Tax payments for equity award issuances (1,584) (1,208)
Distributions to noncontrolling interests (73) (339)
Principal payments on finance leases (5,117) (4,903)
Other 231 (55)
Net cash used in financing activities (26,148) (52,751)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (196) 641
Change in cash, cash equivalents, and restricted cash (8,460) (4,656)
Cash, cash equivalents, and restricted cash at beginning of period 36,950 37,955
Cash, cash equivalents, and restricted cash at end of period $ 28,490 $ 33,299

Source

10-Q PDF XBRL Zip